Dispose of needles in a sharps container so they may be disposed of without risk of needlestick injury
Aug 19 2015;63(32):7108-23
Ozempic, Wegovy, and Mounjaro have been linked to gastroparesis and bowel obstruction, and Alexander Shunnarah Trial Attorneys represents GLP-1 weight loss drug victims across Alabama
Six Phase I/II clinical trials enrolling approximately 900 participants confirmed an excellent safety profile with no serious adverse events attributed to the compound
In 2023 the firm abandoned development of lotiglipron after trial participants showed elevated liver enzymes, and the same year discontinued a twice-daily danuglipron dosing regime after almost three quarters of treated patients experienced nausea, while almost a half developed vomiting and a quarter diarrhoea
GLP-1 drugs, which mimic one or more gut hormones, act on the body in ways both known and yet to be discovered